Caricamento...
Real-World Economic Impact of OnabotulinumtoxinA in Patients With Chronic Migraine
OBJECTIVE: To determine whether the utilization of healthcare resources is reduced after chronic migraine patients are treated for 6 months with onabotulinumtoxinA. BACKGROUND: OnabotulinumtoxinA is indicated for headache prophylaxis in patients with chronic migraine, but its effect on healthcare re...
Salvato in:
| Pubblicato in: | Headache |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BlackWell Publishing Ltd
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4282490/ https://ncbi.nlm.nih.gov/pubmed/25298117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.12456 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|